Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Shares of Aurora Cannabis Inc. ACB slid 1.05% to $4.73 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to ...

Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsKevin Niland - Director, Strategic ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

Aurora Cannabis' profit rose in its fiscal second quarter thanks to a strong performance from its medical cannabis unit. For the three months ended Sept. 30, the Canadian medical cannabis company on ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Aurora Cannabis (TSE:ACB) has released an update. Aurora Cannabis reported impressive fiscal 2025 second-quarter results, achieving a record ...